Google DeepMind launches AlphaGenome Atlas to map gene variants

This moves AI from protein structure into population-scale genomics, effectively creating a reference layer for variant interpretation. The scale—9 billion variants in a petabyte-scale database—positions it as a potential standard for clinical genetics and research pipelines, but its real-world utility hinges on validation against observed patient data and functional assays. The open question is whether AVI scores will be adopted by diagnostic labs and drug developers as a primary filter, or remain one input among many. Watch for independent benchmarking and how regulators treat AI-derived pathogenicity claims in clinical settings.